DI
GILD icon

DDFG Inc’s Gilead Sciences GILD Stock Holding History

DDFG Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$340K Sell
2,280
-15
-0.7% -$2.1K 0.07% 70
2026
Q2 		$290K Buy
2,295
+7
+0.3% +$922 0.06% 77
2026
Q1 		$319K Buy
2,288
+12
+0.5% +$1.68K 0.07% 68
2025
Q4 		$279K Buy
2,276
+36
+2% +$4.38K 0.06% 73
2025
Q3 		$249K Buy
2,240
+14
+0.6% +$1.59K 0.06% 74
2025
Q2 		$247K Buy
2,226
+13
+0.6% +$1.38K 0.06% 70
2025
Q1 		$248K Sell
2,213
-783
-26% -$80.8K 0.07% 65
2024
Q4 		$277K Buy
2,996
+21
+0.7% +$1.89K 0.08% 65
2024
Q3 		$249K Buy
+2,975
New +$227K 0.07% 69
2024
Q1 		– Sell
-4,319
Closed -$350K – 76
2023
Q4 		$350K Buy
4,319
+41
+1% +$3.19K 0.12% 54
2023
Q3 		$321K Buy
4,278
+42
+1% +$3.23K 0.12% 54
2023
Q2 		$327K Buy
4,236
+41
+1% +$3.27K 0.12% 54
2023
Q1 		$348K Buy
4,195
+39
+0.9% +$3.23K 0.14% 51
2022
Q4 		$357K Buy
+4,156
New +$329K 0.15% 47

Other funds holding GILD

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

DDFG Inc's GILD Position: Q3 2026 in Review

DDFG Inc reduced its Gilead Sciences (GILD) stake by 0.65% in Q3 2026, selling an estimated $2.1K and leaving 2,280 shares worth $340K. The position accounts for 0.07% of the portfolio, ranked #70.

DDFG Inc first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $357K in Q4 2022. 1,616 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • DDFG Inc held 2,280 shares of Gilead Sciences worth $340K as of Q3 2026.
  • DDFG Inc sold 15 Gilead Sciences shares in Q3 2026, an estimated $2.1K.
  • Gilead Sciences made up 0.07% of DDFG Inc's portfolio in Q3 2026, its #70 holding.
  • DDFG Inc first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • DDFG Inc's Gilead Sciences position peaked at $357K in Q4 2022.
  • 1,616 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on DDFG Inc's 13F filing for Q3 2026, filed 15 Oct 2026.